RSV

Severe RSV disease remains a serious threat

Recent studies show a trend in increased RSV hospitalizations and complications among high-risk infants1-4

SENTINEL1 study:

A study of preterm infants 29-35 wGA hospitalized with laboratory-confirmed RSV during the 2014-2015 and 2015-2016 RSV seasons1

Kong et al study:

A study of hospitalization rates in commercially insured and Medicaid-insured preterm and full-term infants across the 2013-2014 and 2014-2015 RSV seasons2

Goldstein et al study:

A study of the risk of RSV hospitalization in commercially insured and Medicaid-insured preterm and full-term infants across all RSV seasons between 2012 and 20163

Friedman et al study:

A 2016 study of RSV hospitalization, mechanical ventilation, and inpatient mortality among children with specific CHD diagnoses during their second year of life4

X


Experts discuss findings of SENTINEL1, Kong et al, and Goldstein et al studies

X


Learning more about the consequences of severe RSV disease for high-risk patients and their families

References

  1. Anderson EJ, DeVincenzo JP, Checchia PA, et al [poster #1279]. Presented at: IDWeek; October 26-30, 2016; New Orleans, LA.
  2. Kong AM, Krilov LR, Fergie J, et al. Am J Perinatol. 2018; 35(02): 192-200.
  3. Goldstein M, Krilov LR, Fergie J, et al. Am J Perinatol. doi:10.1055/s-0038-1660466.
  4. Friedman D, Fryzek J, Jiang X, et al. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One. 2017; 12(3):e0172512. doi:10.1371/journal.pone.0172512.